ArticleEmerging infectious diseases2004
Immunofluorescence assay for serologic diagnosis of SARS.
Article in Emerging infectious diseases, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 62 citations in OpenAlex.
- Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2004Trial
- Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy.iScience · 2023Article
- COVID-19 versus SARS: A comparative review.Journal of infection and public health · 2021Review
- Advanced microscopy technologies enable rapid response to SARS-CoV-2 pandemic.Cellular microbiology · 2021Review
- Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human sera: A semi-quantitative, high throughput, microscopy-based assay expands existing approaches to measure SARS-CoV-2 specific antibody levels in human sera.BioEssays : news and reviews in molecular, cellular and developmental biology · 2021Article
- Serological assays and host antibody detection in coronavirus-related disease diagnosis.Archives of virology · 2021Review
- COVID-19 Impact on Diagnostic Innovations: Emerging Trends and Implications.Diagnostics (Basel, Switzerland) · 2021Article
- SARS-CoV: Lessons learned; opportunities missed for SARS-CoV-2.Reviews in medical virology · 2021Review
- Clinical Symptoms and Types of Samples Are Critical Factors for the Molecular Diagnosis of Symptomatic COVID-19 Patients: A Systematic Literature Review.International journal of microbiology · 2021Review
- Clinical evaluation of SARS-CoV-2 point-of-care antibody tests.Pathology · 2020Article
- Biosensor and molecular-based methods for the detection of human coronaviruses: A review.Molecular and cellular probes · 2020Review
- SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays.Clinica chimica acta; international journal of clinical chemistry · 2020Article
- Molecular and Immunological Diagnostic Techniques of Medical Viruses.International journal of microbiology · 2020Review
- COVID-19 rapid diagnostic test could contain transmission in low- and middle-income countries.African journal of laboratory medicine · 2020Review
- Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19.Frontiers in molecular biosciences · 2020Article
- Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.Frontiers in immunology · 2020Review
- Serological assays for emerging coronaviruses: challenges and pitfalls.Virus research · 2014Review
- Influence of HLA gene polymorphisms on susceptibility and outcome post infection with the SARS-CoV virus.Virologica Sinica · 2014Article
- A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications.Trends in biotechnology · 2013Review
- Diagnostics of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid antigen using chicken immunoglobulin Y.Poultry science · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We evaluated an indirect immunofluorescence assay based on virus-infected cells for detecting anti-severe acute respiratory syndrome-associated coronavirus (SARS-CoV) immunoglobulin (Ig) G antibody. All confirmed SARS cases demonstrated seroconversion or fourfold rise in IgG antibody titer; no control was positive. Sensitivity and specificity of this assay were both 100%. Immunofluorescence assay can ascertain the status of SARS-CoV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.